Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.33% |
| 2 | Healthcare | 16.97% |
| 3 | Consumer Discretionary | 12.86% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Excelerate Energy
EE
$1.12B
| $1.41M | ﹤0.01% |
69,200
-5,000
| -7% | -$104K |
|
2227
ProShares UltraPro Short Dow 30
SDOW
$185M
| $1.4M | ﹤0.01% |
+14,675
| New | +$1.5M |
|
|
ZYXI
2228
DELISTED
Zynex
ZYXI
| $1.4M | ﹤0.01% |
146,135
+44,600
| +44% | +$463K |
|
2229
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.07B
| $1.4M | ﹤0.01% |
69,400
-20,457
| -23% | -$417K |
|
|
LAZR
2230
DELISTED
Luminar Technologies
LAZR
| $1.4M | ﹤0.01% |
13,550
-219,670
| -94% | -$20.8M |
|
|
WHWK
2231
Whitehawk Therapeutics
WHWK
$269M
| $1.4M | ﹤0.01% |
204,122
-121,602
| -37% | -$945K |
|
|
SILV
2232
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $1.4M | ﹤0.01% |
+238,141
| New | +$1.56M |
|
|
EVA
2233
DELISTED
Enviva Inc.
EVA
| $1.4M | ﹤0.01% |
128,700
-17,300
| -12% | -$252K |
|
2234
Curis
CRIS
$3.91M
| $1.4M | ﹤0.01% |
4,203
+134
| +3% | +$43.6K |
|
2235
iShares Core Moderate Allocation ETF
AOM
$1.78B
| $1.39M | ﹤0.01% |
34,500
-5,100
| -13% | -$204K |
|
|
ADAP
2236
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.39M | ﹤0.01% |
1,506,375
+1,323,675
| +725% | +$1.58M |
|
|
STKL
2237
DELISTED
SunOpta
STKL
| $1.39M | ﹤0.01% |
208,138
+26,200
| +14% | +$197K |
|
2238
Citizens & Northern Corp
CZNC
$466M
| $1.39M | ﹤0.01% |
72,041
+1,100
| +2% | +$21.6K |
|
2239
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$16.1B
| $1.39M | ﹤0.01% |
+15,900
| New | +$1.32M |
|
2240
iShares Global Clean Energy ETF
ICLN
$2.11B
| $1.39M | ﹤0.01% |
+75,304
| New | +$1.42M |
|
2241
Vanguard S&P 500 Value ETF
VOOV
$6.8B
| $1.39M | ﹤0.01% |
+8,900
| New | +$1.32M |
|
2242
iShare MSCI Eurozone ETF
EZU
$9.96B
| $1.38M | ﹤0.01% |
+30,200
| New | +$1.38M |
|
2243
Worthington Enterprises
WOR
$2.78B
| $1.38M | ﹤0.01% |
+32,278
| New | +$1.2M |
|
2244
SITE Centers
SITC
$156M
| $1.38M | ﹤0.01% |
133,943
-256,422
| -66% | -$2.45M |
|
2245
Corporacion America
CAAP
$6.43B
| $1.38M | ﹤0.01% |
118,961
+38,861
| +49% | +$427K |
|
2246
Invesco Aerospace & Defense ETF
PPA
$8.68B
| $1.38M | ﹤0.01% |
16,300
+9,600
| +143% | +$775K |
|
2247
ALX Oncology
ALXO
$278M
| $1.37M | ﹤0.01% |
182,800
+55,981
| +44% | +$366K |
|
2248
8x8 Inc
EGHT
$290M
| $1.37M | ﹤0.01% |
323,788
-130,442
| -29% | -$470K |
|
2249
Sinclair Inc
SBGI
$1.03B
| $1.37M | ﹤0.01% |
99,155
-318,816
| -76% | -$5.26M |
|
2250
Structure Therapeutics
GPCR
$3.83B
| $1.37M | ﹤0.01% |
+32,900
| New | +$922K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.